Table 2. Clinical data at baseline and treatment effect.

	Patients (n=42)
Median age (range), years	72 (54–86)
Male: female, n	24:18
Location of tumor, n
Head of pancreas	6
Body or tail of pancreas	36
Clinical stage, n
III	18
IV	24
Median KPS score (range)	70 (50–90)
Diameter of tumor under EUS, Mean ± standard deviation, cm	3.13 ± 1.62
Median follow-up period (range), months	10.5 (4–24)
Treatment effect
CR	0
PR	12
SD	21
Progressive disease	9
Serious complications	0